ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,951.20
      0.53%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.225
      -0.22%
      Bitcoin
      56,990.90
      0.50%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axonics Inc (AXNX)

      7. Axonics Inc (AXNX) News

      AXNX

      Axonics (AXNX)

      Axonics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXNX
      DateTimeSourceHeadlineSymbolCompany
      01/25/20214:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXNXAxonics Inc
      01/25/20214:01PMBusiness WireAxonics® Reports Preliminary Fourth Quarter and Fiscal Year 2020 RevenueNASDAQ:AXNXAxonics Inc
      12/14/20205:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXNXAxonics Inc
      12/14/20208:00AMBusiness WireAxonics® Announces Appointment of David M. Demski to Board of DirectorsNASDAQ:AXNXAxonics Inc
      11/19/20206:00AMBusiness WireAxonics® to Participate in Piper Sandler Virtual Healthcare ConferenceNASDAQ:AXNXAxonics Inc
      11/10/20206:00AMBusiness WireAxonics® Announces Publication of Fecal Incontinence Study Results for Patients Treated with r-SNM® SystemNASDAQ:AXNXAxonics Inc
      11/06/20206:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXNXAxonics Inc
      11/04/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXNXAxonics Inc
      11/04/20204:00PMBusiness WireAxonics® Reports Third Quarter 2020 ResultsNASDAQ:AXNXAxonics Inc
      10/29/20206:00AMBusiness WireAxonics® Submits PMA Supplement to FDA to Further Expand MRI LabelingNASDAQ:AXNXAxonics Inc
      10/20/20208:00AMBusiness WireAxonics® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM SystemNASDAQ:AXNXAxonics Inc
      10/14/20206:00AMBusiness WireAxonics® to Report Third Quarter 2020 Results on November 4NASDAQ:AXNXAxonics Inc
      10/07/20204:00PMBusiness WireAxonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Winner for Orange CountyNASDAQ:AXNXAxonics Inc
      10/05/20206:23PMBusiness WireAxonics® annonce les résultats d’une étude réalisée auprès des patients traités au moyen du Système Axonics r-SNM...NASDAQ:AXNXAxonics Inc
      10/05/20203:35PMBusiness WireAxonics® gibt Ergebnisse einer Erhebung bei Patienten bekannt, die mit dem Axonics r-SNM-System behandelt wurden und denen z...NASDAQ:AXNXAxonics Inc
      10/05/20208:00AMBusiness WireAxonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with Inte...NASDAQ:AXNXAxonics Inc
      09/24/20206:00AMBusiness Wire Axonics® Provides Update on Inter Partes Review ProceedingsNASDAQ:AXNXAxonics Inc
      09/23/20207:00AMGlobeNewswire Inc.Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare CompaniesNASDAQ:AXNXAxonics Inc
      09/22/20206:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXNXAxonics Inc
      09/21/20206:00AMBusiness WireAxonics® Receives Health Canada Approval of Next Generation Implantable NeurostimulatorNASDAQ:AXNXAxonics Inc
      09/16/20209:00AMBusiness WireAxonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Finalist for Orange CountyNASDAQ:AXNXAxonics Inc
      09/10/20209:04PMBusiness WireAxonics® publie les résultats cliniques sur 2 ans de l'étude pivot ARTISAN-SNMNASDAQ:AXNXAxonics Inc
      09/10/20205:52PMBusiness WireAxonics® berichtet 2-Jahres-Ergebnisse aus der ARTISAN-SNM-PivotalstudieNASDAQ:AXNXAxonics Inc
      09/10/20206:00AMBusiness WireAxonics® Reports 2-Year Clinical Results from ARTISAN-SNM Pivotal StudyNASDAQ:AXNXAxonics Inc
      09/08/20208:28PMBusiness WireNICE recommande le système Axonics® r-SNM pour le traitement de l'hyperactivité vésicaleNASDAQ:AXNXAxonics Inc
      09/08/20208:27PMBusiness WireNICE empfiehlt Axonics® r-SNM System zur Behandlung der überaktiven BlaseNASDAQ:AXNXAxonics Inc
      09/08/20208:30AMBusiness WireNICE Recommends Axonics® r-SNM System for Treating Overactive BladderNASDAQ:AXNXAxonics Inc
      09/03/20206:00AMBusiness WireAxonics® to Participate in Upcoming Investor ConferencesNASDAQ:AXNXAxonics Inc
      09/02/20207:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXNXAxonics Inc
      09/02/202010:00AMBusiness WireAxonics® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9NASDAQ:AXNXAxonics Inc
       Showing the most relevant articles for your search:NASDAQ:AXNX